Open AccessApplication of Alemtuzumab to Myeloablative Conditioning in Transfusion Dependent Beta-Thalassemia to Reduce Graft-Versus-Host Disease (GVHD)
Author(s) -
Anil George,
Khaled Yassine,
Erin Doherty,
David Steffin,
John Craddock,
Swati Naik,
Ghadir Sasa,
Bilal Omer,
Saleh Bhar,
Caridad Martinez,
Robert A. Krance,
Kathryn Leung,
Tami John
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.541
Subject(s) - medicine , alemtuzumab , busulfan , fludarabine , gastroenterology , hematopoietic stem cell transplantation , cyclophosphamide , graft versus host disease , surgery , transplantation , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom